On March 1, 2022 Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, reported that it will participate in several upcoming investor conferences (Press release, Molecular Templates, MAR 1, 2022, View Source [SID1234609303]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details can be found below:

Cowen’s 42nd Annual Health Care Conference (March 7-9, 2022)
Format:
Corporate Presentation
Date: Tuesday, March 8th
Time: 10:30 AM – 11:00 AM ET

Oppenheimer’s 32nd Annual Healthcare Conference (March 15-16, 2022)
Format:
Corporate Presentation
Date: Wednesday, March 16
Time: 2:00 PM – 2:30 PM ET

Barclays Global Healthcare Conference 2022 (March 15-17, 2022)
Format:
Corporate Presentation
Date: Tuesday, March 15
Time: 4:20 PM – 4:45 PM ET
Webcast links for the presentations will be posted on the "News and Media" section of the Molecular Templates corporate website, under Events.